Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_assertion type Assertion NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_head.
- NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_assertion description "[When the optimized method was applied to the v-abl-transformed NIH 3T3-, the K 562 CML blast cell line and to nine cases of lowly malignant non-Hodgkin lymphomas it semiquantitatively discriminated the varying amounts of v-abl, bcr/c-abl and c-abl mRNA expressed within these cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_provenance.
- NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_assertion evidence source_evidence_literature NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_provenance.
- NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_assertion SIO_000772 2651801 NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_provenance.
- NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_assertion wasDerivedFrom befree-2016 NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_provenance.
- NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_assertion wasGeneratedBy ECO_0000203 NP1295344.RASygLYAZCNS-egrVaIWrIusY744BPvmM9TlgGcv5uu1U130_provenance.